Hjem › Multipel sklerose › Californien
Multipel sklerose kliniske forsøg i Californien
24 studier for Multipel sklerose søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Fresno
- TG Therapeutics Investigational Trial Site, Newport Beach
- TG Therapeutics Investigational Trial Site, Orange
- og 1 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0114, Loma Linda
- University of California Davis Health, Sacramento
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 10. sep. 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07304154Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 64 · Kvinder · Opdateret 11. aug. 2026 · NCT06940323A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
RekruttererFase 1/2
Alder 18 til 55 · Alle køn · Opdateret 2. jul. 2026 · NCT05359653Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
- Byers Hall, San Francisco
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT07510607ECoG BMI for Motor and Speech Control
- University of California San Francisco, San Francisco
Rekrutterer
Alder 21 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT03698149Care in Multiple Sclerosis (MS)
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT07011914Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
RekruttererFase 1
Alder 18 til 60 · Alle køn · Opdateret 23. mar. 2026 · NCT07139743Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- University of California San Francisco, San Francisco
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 11. mar. 2026 · NCT02521311A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 27. feb. 2026 · NCT06138132Central Vein Sign in Multiple Sclerosis Extension Study
- Cedars-Sinai Medical Center, Los Angeles
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 20. feb. 2026 · NCT07424027"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 31. okt. 2025 · NCT07222618Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 80 · Alle køn · Opdateret 2. maj 2025 · NCT05395624Kesimpta (Ofatumumab) Pregnancy Registry
- University of California San Diego OTIS, La Jolla
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 100 · Alle køn · Opdateret 14. jan. 2025 · NCT05634967Entire-body PET Scans for Multiple Sclerosis
- Brain Health Alliance, Ladera Ranch
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 25 til 55 · Alle køn · Opdateret 7. jan. 2025 · NCT04390009Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- Novartis Investigative Site, La Jolla
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Kvinder · Opdateret 16. maj 2024 · NCT04933552MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomneNævner betaling til deltagere
Alder 18 og opefter · Alle køn · Opdateret 6. feb. 2024 · NCT05204459Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.